CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in GALT — Galectin Therapeutics Inc
CIK 884546
SAN FRANCISCO, CA
Position in GALT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$83,727
-$41,010 QoQ
Shares Held
30,010
+0.1% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. GALT ranks #272 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in GALT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,727 | 30,010 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $124,737 | 29,985 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $190,753 | 44,989 | Shares | Sole | 2025-11-10 | |
| 2025-03-31 | $27,953 | 22,913 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $83,944 | 65,073 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $178,950 | 65,073 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $147,064 | 65,073 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $41,617 | 17,413 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $28,905 | 17,413 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $33,432 | 17,413 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $25,074 | 17,413 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $36,567 | 17,413 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,676 | 17,413 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $28,383 | 17,413 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,811 | 17,413 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $28,034 | 17,413 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $36,044 | 17,413 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $67,562 | 17,413 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $55,721 | 17,413 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $168,148 | 77,488 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $191,522 | 85,501 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $228,287 | 85,501 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $284,393 | 92,939 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $181,190 | 92,444 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||